scorecardresearch
Add as a preferred source on Google
Tuesday, December 2, 2025
TopicBreast cancer

Topic: breast cancer

5-yr breast cancer survival rate a dismal 66.4% in India with regional disparity, finds ICMR-led study

The study, published in American Cancer Society Journal, shows survival rate 5 yrs after diagnosis ranges from 41.9% in Pasighat to 74.9% in Mizoram. In countries like US, it's over 90%.

On dead patient’s plea, HC asks Centre for ‘best option’ to make affordable breast cancer meds available

Directive comes on 2022 plea filed by patient seeking Kerala HC's intervention to urge govt to help slash price of a critical cancer drug. She died during the course of the case.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

Cancer cases in under-50s rises by nearly 80% worldwide in last 30 years, finds BMJ study

The research found that the fastest rise was in windpipe and prostate cancers while the heaviest death toll was seen for cancers of breast, windpipe, lung, bowel, and stomach.

Asian women at higher risk of breast & cervical cancers; India lacks elimination targets: Study

Asia was also found to have the world's highest death rate from cervical cancer, with more than 58 per cent related to it.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

Why women with stage 4 breast cancer deserve more than unrelatable pink ribbons

Many women with metastatic breast cancer feel that little is done to showcase the less optimistic and more frightening aspects of the disease.

Experimental drug shows success in advanced breast cancer patients, better than standard chemo

Trastuzumab deruxtecan helped check cancer growth in even those with low levels of protein that cancer drugs target. Tumours didn't grow for at least 10 months, compared to average 5 in chemotherapy.

Rise of breast cancer in Indian women is alarming but expected. It’s your ‘Western’ diet

If news of breast cancer cases rising among women is shocking, it's time to leave your 'inflammatory diet'. Here's a healthier model.

1 in 7 women aged 50-74 who undergo mammogram ‘overdiagnosed’ for breast cancer, finds US study

US study looked at nearly 36,000 women who underwent screening & found that in many cases pre-cancers may not have grown into full malignancy before the women died of other causes.

On Camera

Make Sanchar Saathi removable. Good intentions don’t excuse State overreach

Compulsion magnifies the risk of function creep. Future updates could quietly expand the app’s capabilities or enable background telemetry far beyond users’ expectations.

New cess on ‘pan masala’ to fund national security and healthcare programmes

The Health Security Se National Security Cess Bill, 2025, explained. Oppn has attacked the proposed cess as 'a new financial burden' on the citizens.

After Op Sindoor, India goes in for more Heron Mk IIs; Israel frontrunner for mega MALE drones deal

Order for 87 MALE drones will be split between 2 Indian firms in 64:36 ratio to ensure there are 2 independent manufacturing lines with at least 60% indigenous components.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.